Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CTLT

Catalent (CTLT) Stock Price, News & Analysis

Catalent logo

About Catalent Stock (NYSE:CTLT)

Key Stats

Today's Range
$63.48
$63.48
50-Day Range
$59.66
$63.48
52-Week Range
$58.28
$63.50
Volume
N/A
Average Volume
2.08 million shs
Market Capitalization
$11.52 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Catalent Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
17th Percentile Overall Score

CTLT MarketRank™: 

Catalent scored higher than 17% of companies evaluated by MarketBeat, and ranked 869th out of 951 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Catalent.

  • Earnings Growth

    Earnings for Catalent are expected to grow by 73.08% in the coming year, from $0.78 to $1.35 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Catalent is -28.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Catalent is -28.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Catalent has a PEG Ratio of 2.69. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Catalent has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for CTLT.
  • Dividend Yield

    Catalent does not currently pay a dividend.

  • Dividend Growth

    Catalent does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CTLT.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Catalent this week, compared to 2 articles on an average week.
Receive CTLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Catalent and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CTLT Stock News Headlines

Crypto Gets Official Government Backing—Here's the Winner
Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really investing in this coin.tc pixel
Lisata Therapeutics signs research license with Catalent
See More Headlines

CTLT Stock Analysis - Frequently Asked Questions

Catalent, Inc. (NYSE:CTLT) issued its earnings results on Tuesday, November, 5th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by $0.18. The firm's revenue for the quarter was up 4.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Catalent investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Exxon Mobil (XOM).

Company Calendar

Last Earnings
11/05/2024
Today
9/24/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:CTLT
CIK
1596783
Employees
16,900
Year Founded
2007

Profitability

EPS (Trailing Twelve Months)
($2.26)
Trailing P/E Ratio
N/A
Forward P/E Ratio
81.38
P/E Growth
2.69
Net Income
-$1.04 billion
Net Margins
-9.28%
Pretax Margin
-7.83%
Return on Equity
-0.66%
Return on Assets
-0.24%

Debt

Debt-to-Equity Ratio
1.38
Current Ratio
2.51
Quick Ratio
1.96

Sales & Book Value

Annual Sales
$4.38 billion
Price / Sales
2.63
Cash Flow
$2.64 per share
Price / Cash Flow
24.04
Book Value
$19.91 per share
Price / Book
3.19

Miscellaneous

Outstanding Shares
181,510,000
Free Float
180,949,000
Market Cap
$11.52 billion
Optionable
Optionable
Beta
1.15

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:CTLT) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners